Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies

Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies

The World Health Organization identifies tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i>, as a leading infectious killer. Although conventional treatments for TB exist, they come with challenges such as a heavy pill regimen, prolonged treatment duration, and a strict sched...

Full description

Bibliographic Details
Main Authors: Mahesh Kumar, Tarun Virmani, Girish Kumar, Rohitas Deshmukh, Ashwani Sharma, Sofia Duarte, Pedro Brandão, Pedro Fonte
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Pharmaceuticals
Subjects:
tuberculosis
ligand
nanoformulation
nanoparticle
patent
mannose
Online Access:https://www.mdpi.com/1424-8247/16/10/1360

Internet

https://www.mdpi.com/1424-8247/16/10/1360

Similar Items